[go: up one dir, main page]

AU2003282510A1 - Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents - Google Patents

Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents

Info

Publication number
AU2003282510A1
AU2003282510A1 AU2003282510A AU2003282510A AU2003282510A1 AU 2003282510 A1 AU2003282510 A1 AU 2003282510A1 AU 2003282510 A AU2003282510 A AU 2003282510A AU 2003282510 A AU2003282510 A AU 2003282510A AU 2003282510 A1 AU2003282510 A1 AU 2003282510A1
Authority
AU
Australia
Prior art keywords
hexahydro
inflammatory agents
compounds useful
benzimidazolone compounds
benzimidazolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003282510A
Other languages
English (en)
Other versions
AU2003282510A8 (en
Inventor
T. G. Murali Dhar
Edwin J. Iwanovicz
Michele Launay
Magali Jeannine Blandine Maillet
Eric Antoine Nicolai
Dominique Potin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2003282510A1 publication Critical patent/AU2003282510A1/en
Publication of AU2003282510A8 publication Critical patent/AU2003282510A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003282510A 2002-10-11 2003-10-09 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents Abandoned AU2003282510A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41793502P 2002-10-11 2002-10-11
US60/417,935 2002-10-11
PCT/US2003/031960 WO2004032861A2 (fr) 2002-10-11 2003-10-09 Composes hexahydro-benzimidazolones utiles en tant qu'agents anti-inflammatoires

Publications (2)

Publication Number Publication Date
AU2003282510A1 true AU2003282510A1 (en) 2004-05-04
AU2003282510A8 AU2003282510A8 (en) 2004-05-04

Family

ID=32094123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003282510A Abandoned AU2003282510A1 (en) 2002-10-11 2003-10-09 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents

Country Status (3)

Country Link
US (1) US6974815B2 (fr)
AU (1) AU2003282510A1 (fr)
WO (1) WO2004032861A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550590B2 (en) 2003-03-25 2009-06-23 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1625122A1 (fr) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Inhibiteurs de dipeptidyl peptidase
US20050070531A1 (en) 2003-08-13 2005-03-31 Syrrx, Inc. Dipeptidyl peptidase inhibitors
US20070060530A1 (en) 2005-09-14 2007-03-15 Christopher Ronald J Administration of dipeptidyl peptidase inhibitors
EP1924567B1 (fr) 2005-09-16 2012-08-22 Takeda Pharmaceutical Company Limited Inhibiteurs de dipeptidylpeptidase
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
WO2008105803A1 (fr) * 2007-02-26 2008-09-04 Larry Schlesinger Formulations topiques contenant un antagoniste du récepteur de leucotriène et utilisations associées
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8481750B2 (en) 2009-06-02 2013-07-09 Boehringer Ingelheim International Gmbh Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amides
ES3041181T3 (en) 2015-12-23 2025-11-07 Univ Sorbonne Agents that inhibit the binding of cfh to cd11b/cd18 and uses thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930005A (en) * 1973-06-15 1975-12-30 Squibb & Sons Inc Antiinflammatory agents and their use
EP0178413A1 (fr) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazoles
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
FR2597478B1 (fr) * 1986-04-21 1988-12-16 Esteve Labor Dr Benzimidazoles et imidazopyridines sulfonamides, leur preparation et leur application en tant que medicaments.
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
US5128359A (en) * 1990-02-16 1992-07-07 Laboratoires Upsa Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation
FR2658511B1 (fr) * 1990-02-16 1992-06-19 Union Pharma Scient Appl Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
US5817661A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
CA2134009C (fr) * 1993-11-11 2005-03-08 Oleg Werbitzky Amidines bicycliques, methode pour leur obtention et leur utilisation comme catalyseur
US5716594A (en) * 1994-06-06 1998-02-10 The Jmde Trust Biotin compounds for targetting tumors and sites of infection
SK117499A3 (en) 1997-03-03 2000-05-16 Boehringer Ingelheim Pharma Small molecules useful in the treatment of inflammatory and immune cell-mediated diseases, small molecules and pharmaceutical composition with their content
DE69839399T2 (de) 1997-08-28 2009-05-20 Novartis Ag Lymphozyten funktion antigen-1 antagonisten
AU1083499A (en) 1997-10-21 1999-05-10 Pharmacia & Upjohn Company Thiadiazoles amides useful as antiinflammatory agents
WO1999020617A1 (fr) 1997-10-21 1999-04-29 Active Biotech Ab Urees thiadiazoles anti-inflammatoires agissant comme inhibiteurs lfa-1 et mac-1
WO1999049856A2 (fr) 1998-03-27 1999-10-07 Genentech, Inc. Antagonistes destines au traitement de troubles induits par le recepteur d'adhesion de cd11/cd18
US6331640B1 (en) 1998-10-13 2001-12-18 Hoffmann-La Roche Inc. Diaminopropionic acid derivatives
US6110922A (en) 1998-12-29 2000-08-29 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
CO5140104A1 (es) 1999-02-16 2002-03-22 Novartis Ag Derivados de mevinolina y preparacion farmaceuticas que los contienen
UA74781C2 (en) 1999-04-02 2006-02-15 Abbott Lab Antiinflammatory and immumosuppressive compounds inhibiting cell adhesion
WO2001007044A1 (fr) 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Petites molecules utiles pour le traitement de maladies inflammatoires
US6492408B1 (en) 1999-07-21 2002-12-10 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
US6365615B1 (en) 1999-07-21 2002-04-02 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
US6350763B1 (en) 1999-07-21 2002-02-26 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammation disease
ATE396722T1 (de) 1999-07-21 2008-06-15 Boehringer Ingelheim Pharma Kleine moleküle zur behandlung von endzündlichen erkrankungen
CA2388639C (fr) 1999-10-20 2007-07-17 Tanabe Seiyaku Co., Ltd. Inhibiteurs d'adhesion cellulaire induite par alphalbeta2
WO2001051508A1 (fr) 2000-01-14 2001-07-19 Science & Technology Corporation @ Unm Peptides inhibiteurs de l'interaction lfa-1/icam-1
US6515124B2 (en) 2000-02-09 2003-02-04 Hoffman-La Roche Inc. Dehydroamino acids
NZ523444A (en) 2000-06-29 2004-12-24 Abbott Lab Aryl phenylcyclopropyl sulphide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
WO2002002539A1 (fr) 2000-06-29 2002-01-10 Abbott Laboratories Derives d'aryle phenylheterocyclyle sulfures et leur utilisation en tant qu'agents immunosuppresseurs anti-inflammatoires inhibant l'adherence cellulaire
US7709520B2 (en) 2000-10-06 2010-05-04 The Texas A&M University System Diindolylmethane and C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
GB0028367D0 (en) 2000-11-21 2001-01-03 Celltech Chiroscience Ltd Chemical compounds
CZ20031380A3 (cs) 2000-11-28 2003-10-15 Genentech, Inc. LFA-1 Antagonistické sloučeniny
AU2002227128A1 (en) * 2000-12-01 2002-06-11 Bristol-Myers Squibb Company Hydantoin compounds useful as anti-inflammatory agents

Also Published As

Publication number Publication date
US20040116467A1 (en) 2004-06-17
WO2004032861A3 (fr) 2004-08-05
US6974815B2 (en) 2005-12-13
WO2004032861A2 (fr) 2004-04-22
AU2003282510A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
IL160990A0 (en) Spiro-hydantoin compounds useful as anti-inflammatory agents
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2003224597A1 (en) Organic compositions
AU2003279366A1 (en) Novel compounds
AU2003285288A1 (en) Composition
AU2003300056A1 (en) Organic compositions
AU2002950744A0 (en) Composition
AU2003220968A1 (en) Anti-inflammatory agent
AU2003235708A1 (en) Polytartrate composition
AU2003282510A1 (en) Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
AU2003208411A1 (en) Anti-glycolytic composition
AU2003269904A1 (en) Antigen-polymer compositions
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003289207A1 (en) Anti-inflammatory agent
AU2003249294A1 (en) Fullerene compounds
AU2002249486A1 (en) Macromolecular compounds as potential anti-inflammatory agents
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AUPS044102A0 (en) New compound
AU2002951868A0 (en) Compound i
AU2003260509A1 (en) Acetylene compounds
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003251259A1 (en) Novel compounds
AU2003255322A1 (en) Compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase